EFFECTIVENESS OF CONVENTIONAL RADIOFREQUENCY OF THE GENICULAR NERVES GUIDED BY SCOPIC VERSUS ULTRASOUND FOR THE TREATMENT OF POSTQUIRURGICAL GONALGIA

NCT06613815 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57

Last updated 2024-09-26

No results posted yet for this study

Summary

Knee osteoarthritis is one of the most common joint conditions in the elderly population, characterized by causing pain, stiffness and functional disability in a significant number of cases.

Retrospective, non-randomized observational study, between January 2019 and January 2024, comparing the analgesic effectiveness of conventional radiofrequency of the geniculate nerves performed in a cohort of patients with a scopy-guided technique (scopic group, N=19) versus the ultrasound-guided technique (US group, N=38) in patients referred to the pain unit for chronic gonalgia of moderate-severe intensity after knee surgery.

The main variable studied was the measurement of pain intensity according to the numerical rating scale (NRS) before performing the technique and at 3, 6 and 12 months after radiofrequency denervation of the geniculate nerves.

Conventional radiofrequency of the geniculate nerves of the knee significantly reduces pain intensity over a period of at least 6 to 12 months in patients with chronic postoperative gonalgia, with the ultrasound-guided technique presenting the lowest scores on the numerical pain scale.

It is a simple technique to perform and with few adverse effects, which allows patients to reduce the dose of opioid drugs they take chronically.

Conditions

  • Knee Osteoarthritisorconventional Radiofrequencyandgeniculated Nerves

Interventions

OTHER

radiofrequency of the geniculate nerves

radiofrequency of the geniculate nerveswith a scopy-guided technique versus the ultrasound-guided technique

Sponsors & Collaborators

  • Fundación Pública Galega Instituto de Investigación Sanitaria.

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2024-01-31
Completion
2024-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06613815 on ClinicalTrials.gov